title: Cardiovascular trials and diabetes treatments: a regulatory maze.
authors.forename: David R
authors.initials: DR
authors.lastname: Matthews
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence*; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000401:mortality; D017277:Drug Approval; D019317:Evidence-Based Medicine / Q000331:legislation & jurisprudence*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D061214:Patient Safety / Q000331:legislation & jurisprudence*; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents